FibroBiologics Secures Australian Patent for Breakthrough Cartilage Regeneration Method

FibroBiologics, , a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential...

April 12, 2024 | Friday | News
Bio-Rad to Invest in Oncocyte for Exclusive Global Transplant Monitoring Technology, Eyeing FDA Clearance and Market Expansion

Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-R...

April 12, 2024 | Friday | News
SaniSure accelerates drug speed to market with Fill4Sure launch

Fill4Sure™ provides an innovative solution to the critical challenges drug manufacturers experience throughout the fill-finish process, such as high ...

April 12, 2024 | Friday | News
Australian Biotech Firm Ferronova Initiates Clinical Trial for FerroTrace® Nanoparticle Technology in Gastric and Oesophageal Cancers

Australian biotech company Ferronova has announced the initiation of a clinical trial of the company’s FerroTrace® nanoparticle technology in pat...

April 10, 2024 | Wednesday | News
Biological Dynamics Expands Adoption of ExoVerita™ Pro Under Early Access Program

“Research has shown that exosomes carry important information about human health, but studying them has proven challenging,” remarked Paul R. B...

April 03, 2024 | Wednesday | News
Agilent Technologies and UC San Diego to Establish Center of Excellence in Cellular Intelligence

Agilent Technologies , a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC Sa...

April 03, 2024 | Wednesday | News
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia

Incyte and China Medical System Holdings Limited  are pleased to announce that on March 31, 2024, Incyte and CMS, through a wholly-owned dermatology m...

April 02, 2024 | Tuesday | News
Akebia's Vafseo® Receives FDA Approval as New Oral Standard of Care for Anemia in Dialysis Patients

   Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted ...

March 28, 2024 | Thursday | News
Actylis and Novo Nordisk Pharmatech A/S Partner to Distribute Pharmaceutical Grade Benzalkonium Chloride in Europe

   Actylis, a global leader in the distribution of critical raw materials for the life sciences industry, has entered into a strategic agreement...

March 26, 2024 | Tuesday | News
Elegen Launches ENFINIA™ DNA Enhancement Enabling Rapid Synthesis of Highly Complex DNA

    Gilles Besin, Ph.D., CSO at Orbital: “Elegen's unique expertise in supplying...IVT-ready synthetic DNA constructs is very attractive ...

March 21, 2024 | Thursday | News
Celanese and Secarna Pharmaceuticals Join Forces to Revolutionize Antisense Therapy Delivery

  ASOs represent a groundbreaking therapeutic approach, targeting specific messenger RNA to impede protein production associated with various disease...

March 21, 2024 | Thursday | News
Lonza Strikes Deal with Roche: Acquires Genentech Facility in Vacaville for $1.2 Billion to Bolster Biologics Manufacturing Capacity

Lonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 billion in cash Vacaville (US) si...

March 20, 2024 | Wednesday | News
Australia's Telix Pharmaceuticals Forges Alliance to Drive Personalized Cancer Treatment

Telix Pharmaceuticals Limited (ASX: TLX) has announced a strategic agreement to partner with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaf...

March 19, 2024 | Tuesday | News
BIO Sets New Strategic Direction on National Security Under Leadership of CEO John F. Crowley

    Why Biotech is a National Security Imperative John F. Crowley, stepping into his role as BIO's President and CEO, ...

March 15, 2024 | Friday | Reports

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in